Half of all humans are affected by oral inflammatory diseases, yet the mechanisms that drive the most aggressive, rapidly destructive forms remain largely unmapped. This study from Nature Communications bridges that gap with extraordinary resolution.

The research team compared peri-implantitis with moderate- and high-grade periodontitis using integrated microbial profiling and single-cell sequencing on over 967,000 cells — an expansion of the Human Periodontal Atlas. Laser capture microdissection combined with compartmental microbiome analysis revealed a striking finding: peri-implantitis sites showed reduced bacterial load and diversity compared to periodontitis, challenging the assumption that microbial burden alone explains tissue destruction.

The single-cell RNA-seq data (36 samples, 121,395 cells) identified rarefaction of CD34+ vascular endothelial cells and enrichment of oxidative stress, hypoxia, and NAD+ metabolism transcriptional programs in a specific TNFRSF6B+/ICAM1+ post-capillary venule subpopulation. The NAD+-consuming ectoenzyme CD38 emerged as the central marker, confirmed orthogonally by spatial transcriptomics (6 samples, 283,377 cells) and proteomics (23 samples, 562,397 cells).

Spatial neighborhood analyses demonstrated that CD38-high post-capillary venule endothelial cells expand, cluster more closely, and sustain elevated IL16-CD4 T cell signaling specifically in peri-implantitis. Matched high-grade periodontitis biopsies confirmed spatially restricted CD38+ endothelial cells despite comparable microbial burden — pointing to endothelial vasculopathy, not bacteria, as the engine of rapidly advancing destruction.

For the clinician, this reframes our understanding: rapidly progressive peri-implantitis and periodontitis share a vascular signature that is independent of microbial load. CD38 represents a potential therapeutic axis — its inhibition could slow the endothelial-driven inflammatory cascade that underlies the most aggressive forms of periodontal and peri-implant disease.